Windlas Biotech Reports Record Quarterly Sales Amid Debt Collection Challenges
Windlas Biotech announced its financial results for the quarter ending December 2024, reporting record net sales and operating profit. However, the company faces challenges with a declining debtors turnover ratio, indicating potential liquidity and operational efficiency concerns. Stakeholders will be closely watching these evolving trends.
Windlas Biotech has reported its financial results for the quarter ending December 2024, showcasing a mix of positive developments and challenges. The company achieved its highest quarterly net sales at Rs 195.02 crore, marking consistent growth over the last five quarters. Additionally, the operating profit reached Rs 24.63 crore, also the highest in the same timeframe, indicating a favorable trend in operational performance.However, the financial results also highlight some areas of concern. The debtors turnover ratio has reached its lowest point in the last five half-yearly periods at 3.72 times, suggesting a slowdown in the company's ability to settle its debts. This aspect may warrant attention as it could impact liquidity and operational efficiency.
Overall, Windlas Biotech has experienced an adjustment in its evaluation, with its score reflecting recent performance metrics. As the company navigates these dynamics, stakeholders will be keen to monitor how these trends evolve in the coming periods.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
